Rational prescribing for patients with a reduced life expectancy

Clinical Pharmacology and Therapeutics

Volumn 85, Issue 1, 2009, Pages 103-107

  Holmes, H M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; CHLORPROPAMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ORAL ANTIDIABETIC AGENT; PETHIDINE; THIAZIDE DIURETIC AGENT; WARFARIN;

AGED; CARDIOVASCULAR DISEASE; COMMUNITY LIVING; DEMENTIA; DRUG INDICATION; DRUG USE; GERIATRIC CARE; HUMAN; LIFE EXPECTANCY; MORTALITY; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL RATE; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEMENTIA; DRUG TOXICITY; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; LIFE EXPECTANCY; MORTALITY; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; TERMINAL CARE;

EID: 57749191477     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.211     Document Type: Review

References (31)

1. Currow, D.C., Stevenson, J.P., Abernethy, A.P., Plummer, J. & Shelby-James, T.M. Prescribing in palliative care as death approaches. J. Am. Geriatr. Soc. 55, 590-595 (2007).
2. Boyd, C.M., Darer, J., Boult, C., Fried, L.P., Boult, L. & Wu, A.W. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294, 716-724 (2005).
3. Holmes, H.M., Hayley, D.C., Alexander, G.C. & Sachs, G.A. Reconsidering medication appropriateness for patients late in life. Arch. Intern. Med. 166, 605-609 (2006).
4. Hajjar, E.R., Cafiero, A.C. & Hanlon, J.T. Polypharmacy in elderly patients. Am. J. Geriatr. Pharmacother. 5, 345-351 (2007).
5. Spinewine, A. et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370, 173-184 (2007).
6. Hilmer, S.N. et al. A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. 167, 781-787 (2007).
7. Carey, E.C., Covinsky, K.E., Lui, L.Y., Eng, C., Sands, L.P. & Walter, L.C. Prediction of mortality in community-living frail elderly people with long-term care needs. J. Am. Geriatr. Soc. 56, 68-75 (2008).
8. Laroche, M.L., Charmes, J.P., Bouthier, F. & Merle, L. Inappropriate medications in the elderly. Clin. Pharmacol. Ther. 85, this issue.
9. Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R. & Beers, M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 163, 2716-2724 (2003).
10. Hanlon, J.T. et al. A method for assessing drug therapy appropriateness. J. Clin. Epidemiol. 45, 1045-1051 (1992).
11. Knight, E.L. & Avorn, J. Quality indicators for appropriate medication use in vulnerable elders. Ann. Intern. Med. 135, 703-710 (2001).
12. Fahlman, C., Lynn, J., Finch, M., Doberman, D. & Gabel, J. Potentially inappropriate medication use by Medicaid+Choice beneficiaries in the last year of life. J. Palliat. Med. 10, 686-695 (2007).
13. Lee, S.P., Bain, K.T. & Maio, V. Appropriate discontinuation of medications at the end of life: a need to establish consensus criteria. Am. J. Med. Qual. 22, 393-394 (2007).
14. De Lima, L. International Association for Hospice and Palliative Care list of essential medicines for palliative care. Ann. Oncol. 18, 395-399 (2007).
15. Walter, L.C. & Covinsky, K.E. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285, 2750-2756 (2001).
16. Cummings, S.R. et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280, 2077-2082 (1998).
17. Ravid, M., Lang, R., Rachmani, R. & Lishner, M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch. Intern. Med. 156, 286-289 (1996).
18. Hajjar, E.R. et al. Adverse drug reaction risk factors in older outpatients. Am. J. Geriatr. Pharmacother. 1, 82-89 (2003).
19. Blass, D.M. et al. Medication use in nursing home residents with advanced dementia. Int. J. Geriatr. Psychiatry 23, 490-496 (2008).
20. Holmes, H.M., Sachs, G.A., Shega, J.W., Hougham, G.W., Cox Hayley, D. & Dale, W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J. Am. Geriatr. Soc. 56, 1306-1311 (2008).
21. Brauner, D.J., Muir, J.C. & Sachs, G.A. Treating nondementia illnesses in patients with dementia. JAMA 283, 3230-3235 (2000).
22. Weschules, D.J., Maxwell, T.L. & Shega, J.W. Acetylcholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use among hospice enrollees with a primary diagnosis of dementia. J. Palliat. Med. 11, 738-745 (2008).
23. Vollrath, A.M., Sinclair, C. & Hallenbeck, J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J. Palliat. Med. 8, 876-881 (2005).
24. Silveira, M.J., Kazanis, A.S. & Shevrin, M.P. Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use. J. Palliat. Med. 11, 685-693 (2008).
25. Rossi, M.I. et al. Polypharmacy and health beliefs in older outpatients. Am. J. Geriatr. Pharmacother. 5, 317-323 (2007).
26. Belcher, V.N., Fried, T.R., Agostini, J.V. & Tinetti, M.E. Views of older adults on patient participation in medication-related decision making. J. Gen. Intern. Med. 21, 298-303 (2006).
27. Kistler, C.E., Lewis, C.L., Amick, H.R., Bynum, D.L., Walter, L.C. & Watson, L.C. Older adults' beliefs about physician-estimated life expectancy: a cross-sectional survey. BMC Fam. Pract. 7, 1-6 (2006).
28. Brown, A.F., Mangione, C.M., Saliba, D. & Sarkisian, C.A. Guidelines for improving the care of the older person with diabetes mellitus. J. Am. Geriatr. Soc. 51, S265-S280 (2003).
29. Huang, E., Gandra, N., Zhang, Q., Chin, M. & Meltzer, D. The impact of functional status and comorbid illness on the expected benefits of intensive glucose control in older diabetes patients. J. Am. Geriatr. Soc. 55, S213-S214 (2007).
30. Krahn, M. & Naglie, G. The next step in guideline development: incorporating patient preferences. JAMA 300, 436-438 (2008).
31. Bain, K.T., Holmes, H.M., Beers, M.H., Maio, V., Handler, S. & Pauker, S. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J. Am. Geriatr. Soc. 2008); e-pub ahead of print 2 September 2008.